Can FFA Eyebrow and Eyelash Loss Be Treated Safely?

Yes, treatments are available that can help protect your eyebrows and eyelashes if you have frontal fibrosing alopecia (FFA). However, because FFA is a condition that destroys hair follicles through scarring, medical treatments are primarily aimed at controlling the active inflammation and preserving the hairs you still have ^[1][2]. Once a hair follicle has been completely replaced by scar tissue, it generally cannot regrow ^[1][2]. Seeking treatment early, before extensive scarring occurs, is the most effective way to maintain your brows and lashes.

Confirming the Cause and Assessing Disease Activity

Before starting any treatment, a dermatologist should evaluate your hair loss to confirm it is caused by FFA—as other conditions can look similar—and determine if the disease is currently active ^[1].

While active disease sometimes causes subtle redness, itching, or scaling around the hair follicles, FFA can also progress without any noticeable symptoms. A lack of symptoms does not guarantee the disease is inactive. To accurately assess whether the condition is active or stable, your dermatologist will likely use specialized magnification (dermoscopy or trichoscopy), compare serial photographs over time, and occasionally perform a biopsy ^[3][4].

Medical Treatment Options and Safety

Treating FFA is highly individualized. Many treatments are used “off-label” (prescribed for FFA though originally approved for other uses) and evidence often comes from small studies or expert consensus rather than large clinical trials ^[5][6]. Your clinician will recommend options based on your overall health, pregnancy potential, and the severity of the inflammation.

Topical and Injection Therapies (Primarily for Eyebrows):

• Topical Medications: Prescription anti-inflammatory creams or ointments, such as topical corticosteroids or calcineurin inhibitors (medications that modify the immune response in the skin), are frequently used on the eyebrows ^[6][7]. Prolonged use of topical steroids near the eye can cause skin thinning and, if exposed to the eye, may increase the risk of elevated eye pressure (glaucoma) or cataracts.
• Steroid Injections: Intralesional triamcinolone is often injected into the eyebrows to calm inflammation ^[6][8]. Because of the proximity to the eye, these injections must be performed by an experienced clinician. Risks include local skin thinning (atrophy) and changes in skin pigmentation ^[8].

Systemic Therapies (For Widespread or Rapidly Progressing Disease):

• Anti-inflammatory and Hormone-Blocking Medications: Options may include hydroxychloroquine (which requires regular eye exams to monitor for retinal toxicity), doxycycline (which can cause gastrointestinal upset and sun sensitivity), or finasteride/dutasteride (which are strictly avoided during pregnancy due to severe fetal risks) ^[5][4][9].
• Oral Minoxidil: Low-dose oral minoxidil may help improve hair coverage by supporting follicles that remain viable, but it does not reverse established scarring or stop the underlying FFA inflammation ^[10][11]. Side effects can include unwanted facial or body hair growth (hypertrichosis), low blood pressure, rapid heart rate, and fluid retention ^[11].

Important Safety Precautions Near the Eyes and Eyelashes

Eyelash involvement in FFA requires special caution. The skin around your eyes is extremely thin, and medications intended for the eyebrows or scalp can cause significant harm if they enter the eye ^[12]. Furthermore, missing eyelashes can leave the eye vulnerable to irritation.

• Follow Instructions Exactly: Use only the exact product, amount, and location instructed by your clinician. Never apply prescription creams or ointments to your eyelids or eyelash margins unless explicitly directed by a specialist with ocular expertise ^[12].
• Accidental Exposure: If a medication accidentally gets into your eye, rinse it out promptly with water. Seek medical advice if you experience pain, persistent irritation, or visual symptoms.
• Knowing When to Seek Eye Care: Eyelash loss or disease activity can contribute to ocular-surface irritation ^[12].
  • Emergency Symptoms: Sudden vision loss, severe eye pain, marked light sensitivity, or significant swelling require immediate, same-day emergency eye care.
  • Prompt Symptoms: Persistent mild itching, redness, or a feeling of a foreign body in the eye should be evaluated promptly by an ophthalmologist to rule out other issues and ensure the surface of your eye is healthy ^[12][13].

Cosmetic Approaches and Camouflage

Because regrowing scarred hair is difficult, camouflage is a practical and empowering way to manage eyebrow and eyelash loss. Losing facial hair can be emotionally difficult, and finding safe cosmetic solutions is a legitimate part of your overall care.

• Makeup and False Lashes: Eyebrow pencils, powders, and false eyelashes are common options. However, cosmetics and lash adhesives can cause allergic contact dermatitis, irritation, or infection, and can pull on fragile remaining hairs. Avoid using these products if your skin or eyes are actively inflamed. When using them, choose clean applicators, consider patch-testing adhesives on your inner arm first, and always remove them gently.
• Tattooing and Micropigmentation: Procedures like microblading or eyebrow tattooing can yield excellent cosmetic results ^[14]. However, any trauma to the skin might potentially trigger a flare-up of FFA (a reaction known as the Koebner phenomenon), though evidence for this is limited ^[14][15]. These procedures also carry risks of infection, allergic reactions, and unpredictable pigment changes. Most specialists recommend waiting until your disease has been clinically inactive for a prolonged period before considering tattoos ^[14].
• Hair Transplantation: Eyebrow transplants have been performed for FFA, but long-term graft durability is a major concern. While early growth can be satisfactory, progressive loss of the transplanted hairs has been reported in several studies by three to five years ^[16][17]. Outcomes are highly variable, and surgery is generally only considered after sustained, clinician-confirmed disease stability ^[2].